← Back to Analyst Consensus 
PBH Buy
Prestige Consumer Healthcare Inc.
Current Price —
Implied Upside —
Analysts 10
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 5, 2026 (10 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| May 15, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| May 14, 2026 | Oppenheimer | downgrade | Outperform → Perform | — | 52% |
| May 7, 2026 | Oppenheimer | maintain | Outperform → Outperform | — | 52% |
| Feb 2, 2026 | Jefferies | maintain | Hold → Hold | $66 | 52% |
| Nov 7, 2025 | Canaccord Genuity | maintain | Buy → Buy | $88 | 48% |
| Oct 27, 2025 | Jefferies | maintain | Hold → Hold | $71 | 52% |
| Oct 21, 2025 | Oppenheimer | maintain | Outperform → Outperform | $72 | 52% |
| Aug 8, 2025 | Canaccord Genuity | maintain | Buy → Buy | $100 | 48% |
| Mar 21, 2025 | RBC Capital | maintain | Sector Perform → Sector Perform | $97 | 55% |
| Feb 13, 2025 | Oppenheimer | maintain | Outperform → Outperform | $93 | 52% |
| Feb 7, 2025 | Canaccord Genuity | maintain | Buy → Buy | $100 | 48% |
| Feb 7, 2025 | DA Davidson | maintain | Buy → Buy | $104 | 55% |
| Nov 11, 2024 | DA Davidson | maintain | Buy → Buy | $95 | 55% |
| Aug 28, 2024 | DA Davidson | maintain | Buy → Buy | $95 | 55% |
| Aug 9, 2024 | DA Davidson | maintain | Buy → Buy | $93 | 55% |
| Aug 9, 2024 | Canaccord Genuity | maintain | Buy → Buy | $81 | 48% |
| Jun 21, 2024 | DA Davidson | upgrade | Neutral → Buy | $93 | 55% |
| May 21, 2024 | Canaccord Genuity | maintain | Buy → Buy | $80 | 48% |
| May 16, 2024 | DA Davidson | maintain | Neutral → Neutral | $65 | 55% |
| Jun 26, 2023 | DA Davidson | reiterate | Neutral → Neutral | $60 | 55% |
| May 8, 2023 | DA Davidson | reiterate | — → Neutral | $60 | 55% |
| Mar 17, 2023 | RBC Capital | maintain | — → Sector Perform | $104 | 55% |
| Feb 17, 2023 | Oppenheimer | maintain | — → Outperform | $71 | 52% |
| Jan 13, 2023 | Oppenheimer | maintain | — → Outperform | $72 | 52% |
| Nov 17, 2022 | Canaccord Genuity | initiate | — → Buy | $71 | 48% |
| May 10, 2022 | Jefferies | upgrade | Hold → Buy | $70 | 52% |
| May 9, 2022 | Oppenheimer | upgrade | Perform → Outperform | $63 | 52% |
| May 9, 2022 | DA Davidson | maintain | — → Neutral | $60 | 55% |
| Nov 15, 2021 | DA Davidson | maintain | — → Neutral | $63 | 55% |
| Aug 6, 2021 | DA Davidson | maintain | — → Neutral | $61 | 55% |
| May 28, 2021 | DA Davidson | maintain | — → Neutral | $52 | 55% |
| May 10, 2021 | DA Davidson | maintain | — → Neutral | $49 | 55% |
| Nov 6, 2020 | DA Davidson | maintain | — → Neutral | $39 | 55% |
| Aug 7, 2020 | DA Davidson | downgrade | Buy → Neutral | $45 | 55% |
| Mar 26, 2020 | Jefferies | upgrade | Hold → Buy | $43 | 52% |
| Mar 24, 2020 | Oppenheimer | initiate | — → Perform | $0 | 52% |
| Mar 19, 2020 | DA Davidson | upgrade | Neutral → Buy | $0 | 55% |
| Nov 4, 2019 | DA Davidson | maintain | — → Neutral | $32 | 55% |
| Jan 15, 2019 | Raymond James | downgrade | Outperform → Market Perform | $0 | 54% |
| Feb 5, 2018 | Keybanc | maintain | Overweight → Overweight | $43 | 53% |
| Feb 5, 2018 | DA Davidson | downgrade | Buy → Neutral | $0 | 55% |
| Dec 4, 2017 | William Blair | upgrade | Market Perform → Outperform | $0 | 48% |
| Nov 15, 2017 | BMO Capital | upgrade | Market Perform → Outperform | $0 | 53% |
| Nov 3, 2017 | Jefferies | maintain | — → Hold | $50 | 52% |
| May 22, 2017 | Raymond James | upgrade | Market Perform → Outperform | $0 | 54% |
| May 9, 2017 | DA Davidson | initiate | — → Buy | $79 | 55% |
| Nov 17, 2016 | Gabelli & Co. | initiate | — → Buy | $0 | — |
| Mar 7, 2016 | Keybanc | initiate | — → Overweight | $0 | 53% |
| Feb 5, 2016 | Piper Sandler | initiate | — → Overweight | $0 | 54% |
| Jan 25, 2016 | Jefferies | maintain | — → Underperform | $41 | 52% |
Price Target Trend
May 12, 2026 Latest: $67.8 Oct 25, 2026
EPS Estimates
+1q $1.24
Lo: $1.20 Hi: $1.31
7 analysts +1y $5.08
Lo: $4.72 Hi: $5.35
8 analysts ▲1
0q $1.07
Lo: $1.05 Hi: $1.08
7 analysts 0y $4.57
Lo: $4.45 Hi: $4.63
8 analysts ▲1
Cross-Platform Signals
No cross-platform signals in the last 90 days